| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-04 08:34 Tx date 2025-05-30 |
$GOOS
Canada Goose Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$322,439
+19,170 vol $16.82 each |
87,919 | |
| Filed 2025-06-04 08:33 Tx date 2025-05-30 |
$GOOS
Canada Goose Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$34,514
+2,052 vol $16.82 each |
4,201 | |
| Filed 2025-06-03 14:39 Tx date 2025-06-02 |
$GOOS
Canada Goose Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-4,049.9345
-257 vol $15.76 each |
2,587 | |
| Filed 2025-06-03 14:39 Tx date 2025-06-02 |
$GOOS
Canada Goose Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
57 - Exercise of rights
|
$10,570
+429 vol $24.64 each |
2,844 | |
| Filed 2025-06-03 14:38 Tx date 2025-06-02 |
$GOOS
Canada Goose Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-10,570.56
-429 vol $24.64 each |
1,720 | |
| Filed 2025-06-03 14:12 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
250,000 | |
| Filed 2025-05-30 16:31 Tx date 2025-05-29 |
$GOOS
Canada Goose Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-5,183.6092
-308 vol $16.83 each |
2,415 | |
| Filed 2025-05-30 16:31 Tx date 2025-05-29 |
$GOOS
Canada Goose Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
57 - Exercise of rights
|
$11,609
+522 vol $22.24 each |
2,723 | |
| Filed 2025-05-30 16:30 Tx date 2025-05-29 |
$GOOS
Canada Goose Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-11,609.28
-522 vol $22.24 each |
2,149 | |
| Filed 2025-05-30 16:30 Tx date 2025-05-28 |
$GOOS
Canada Goose Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-5,906.7679
-341 vol $17.32 each |
2,201 | |
| Filed 2025-05-30 16:29 Tx date 2025-05-28 |
$GOOS
Canada Goose Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
57 - Exercise of rights
|
$11,350
+598 vol $18.98 each |
2,542 | |
| Filed 2025-05-30 16:29 Tx date 2025-05-28 |
$GOOS
Canada Goose Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-11,350.04
-598 vol $18.98 each |
2,671 | |
| Filed 2025-03-20 12:26 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+50,000 vol |
550,000 | |
| Filed 2025-03-20 12:26 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-50,000 vol |
0 | |
| Filed 2024-12-10 14:00 Tx date 2024-12-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+50,000 vol |
500,000 | |
| Filed 2024-12-10 13:58 Tx date 2024-12-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-50,000 vol |
50,000 | |
| Filed 2024-12-02 19:22 Tx date 2024-11-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+100,000 vol |
450,000 | |
| Filed 2024-12-02 19:21 Tx date 2024-11-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-100,000 vol |
100,000 | |
| Filed 2024-11-29 13:50 Tx date 2024-11-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$122,500,000,000
+350,000 vol $350,000 each |
350,000 | |
| Filed 2024-11-29 13:50 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|